POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH PTH 1-84: EVALUATION OF OUTCOMES

被引：0
|
作者：
Pastore, Renato [1 ]
Chioma, Laura [2 ]
Borboni, Patrizia [2 ]
Vancieri, Giuseppe [2 ]
Mentuccia, Daniela [1 ]
Frajese, Giovanni Vanni [3 ]
机构：
[1] Osped Fatebenefratelli S Giovanni Calibita Isola, UOC Endocrinol, Rome, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Cassino, Fac Sci Motorie & Salute, Frosinone, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of 36 months treatment of postmenopausal osteoporotic women with PTH (1-84)
    Recker, R. R.
    Zanchetta, J. R.
    Mautalen, C. A.
    Man, Z.
    Leib, E. S.
    Morris, S. A.
    Greisen, H.
    Fox, J.
    BONE, 2009, 44 (02) : S431 - S431
  • [2] PERCUTANEOUS VERTEBROPLASTY FOR OSTEOPOROTIC COMPRESSION FRACTURES IN POSTMENONPAUSAL WOMEN TREATED WITH PTH 1-84: EFFICACY AND EVALUATION OF SHORT-TERM OUTCOMES
    Diaz De Atauri, J.
    Mhaidli, H.
    Montesdeoca, A.
    Lorenzo, J. A.
    Fernandez, T.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 182 - 182
  • [3] Safety indices from iliac crest biopsies from postmenopausal osteoporotic women after 36 months of treatment with PTH (1-84)
    Recker, R. R.
    Zanchetta, J. R.
    Mautalen, C. A.
    Leib, E. S.
    Greisen, H.
    Morris, S. A.
    Fox, J.
    BONE, 2009, 44 (02) : S431 - S432
  • [4] Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84
    Recker, R. R.
    Bare, S. R.
    Smith, S. Y.
    Varela, A.
    Miller, M. A.
    Morris, S. A.
    Fox, J.
    BONE, 2009, 44 (01) : 113 - 119
  • [5] CORRELATION BETWEEN BMD PERCENTAGE CHANGE AND TEN-YEAR PROBABILITY OF MAJOR OSTEOPOROTIC FRACTURE BY FRAX® AND HYPOVITAMINOSIS D IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH PTH 1-84: EFFICACY AND TOLERABILITY
    Filgueira, J.
    Torreq, M.
    Lopew Paredes, C.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 188 - 188
  • [6] Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study
    Zanchetta, Jose R.
    Bogado, Cesar E.
    Cisari, Carlo
    Aslanidis, Spyros
    Greisen, Hanna
    Fox, John
    Lems, Willem
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (11) : 2627 - 2633
  • [7] Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women
    Adami, Silvano
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3259 - 3274
  • [8] Atrophic femoral bone nonunion treated with 1-84 PTH
    Paridis, D.
    Karachalios, Th.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2011, 11 (04) : 320 - 323
  • [9] Sequential treatment with full-length parathyroid PTH(1-84) of postmenopausal women with primary osteoporosis
    Felsenberg, D.
    Delmas, P.
    Hosking, D.
    Rizzoli, R.
    Brandi, M.
    Diaz-Curiel, M.
    Hyldstrup, L. H.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S126 - S126
  • [10] Continued increase in hip BMD after 36 months of PTH(1-84) treatment in postmenopausal, women
    Jodar-Gimeno, E.
    Leib, E. S.
    Zanchetta, J. R.
    Mautalen, C. A.
    Greisen, H.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S231 - S231
12345